Keyword: Pharmstandard

News

Aveo Licenses Antibody to Novartis for Treatment of Cachexia

19.08.2015 - US biopharmaceutical company Aveo Oncology has entered into a global license agreement with Novartis for its AV-380 and related antibodies. AV-380 is a potent inhibitory antibody...

Plant Construction & Process Technology

Russia’s and Eastern Europe’s Booming Pharma Industry

28.10.2013 - Potential For Success - There is great promise for innovative R&D, generics and active pharmaceutical ingredient (API) manufacture in Russia and the countries that make up Central...

News

Pharmstandard to Buy Ingredient Supplier for $590 Million

15.08.2013 - Russian drugmaker Pharmstandard has agreed to buy a supplier of ingredients for its flagship anti-viral and anxiety drugs for $590 million, as part of a plan to spin off its over...

News

Russia’s Pharmstandard To Spin Off Over-The-Counter Business

09.07.2013 - Pharmstandard, Russia's leading drugmaker has started steps to spin off its over-the-counter medicines business, it said on Monday. The Russian company, majority owned by...

News

Small Generic Drug Firms Need Niches to Survive Looming Price War

21.07.2012 - Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...